Inventor
XIANGYANG YE
Inventor
CN
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds38%
A61KPreparations for medical, dental or toiletry purposes31%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
PatentTitleYear
12,415,797Heterocyclic compound as CDK-HDAC double-channel inhibitor202512,358,911Heterocyclic comipound as CDK-HDAC dual pathway inhibitor202511,352,353Heterocyclic compound serving as FGFR4 inhibitor202211,266,640Polycyclic compound acting as IDO inhibitor and/or IDO-HDAC dual inhibitor202211,142,535Heterocyclic compound as Syk inhibitor and/or Syk-HDAC dual inhibitor2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to HANGZHOU INNOGATE PHARMA CO LTD (5)· patent assignee history
2021–2025Based in CN· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| HANGZHOU INNOGATE PHARMA CO LTD | 5 | 2021–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| CN | 5 | 2021–2025 |